Skip to content

Investigation Into the Correlation of Plasma Hs-CRP Concentrations and Cardiovascular Risk in Korean Population

Investigation Into the CorrelAtion of pLasma Hs-CRP Concentrations and cardiovascuLar rISk in Korean populaTiOn

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00819273
Acronym
CALLISTO
Enrollment
1700
Registered
2009-01-08
Start date
2009-03-31
Completion date
2009-08-31
Last updated
2010-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hsCRP

Keywords

hsCRP

Brief summary

An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects with at least one clinic visit record within the last 12 months from the date of data entry. * Subjects with at least one hs-CRP level measured within the last 12 months from the date of data entry.

Exclusion criteria

* Use of statins or other lipid-lowering therapies including fibrates, niacin, and bile acid sequestrants in the past 3 months prior to hsCRP measurement * Active inflammatory diseases documented during the period of CRP measurement * Subjects taking immunosuppressants * Findings of chronic inflammation: arthritis, lupus, or inflammatory bowel disease

Design outcomes

Primary

MeasureTime frame
Evaluate hs-CRP levels according to risk categories by the NCEP ATP III.Within the last 12 months from the date of data entry.

Secondary

MeasureTime frame
Evaluate a relationship between hs-CRP and each CHD CVD risk factor including LDL-C.Within the last 12 months from the date of data entry.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026